Viewing Study NCT03590405


Ignite Creation Date: 2025-12-25 @ 3:21 AM
Ignite Modification Date: 2025-12-26 @ 1:59 AM
Study NCT ID: NCT03590405
Status: COMPLETED
Last Update Posted: 2021-12-15
First Post: 2018-06-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC
Sponsor: Sahlgrenska University Hospital
Organization:

Study Overview

Official Title: Uterus Transplantation LD - Feasibility Study - Sahlgrenska - Bellevue Medical Centre
Status: COMPLETED
Status Verified Date: 2021-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GOT-BMC-UTx
Brief Summary: Medical know-how concerning uterus transplantation will be transferred to new site by structured process involving theory, animal workshops and a clinical feasibility study on human subjects.
Detailed Description: Medical know-how concerning uterus transplantation will be transferred to new site by structured process involving theory, animal workshops and surgery.

Theory and common animal workshops have been ongoing for 3 years. The team from Bellevue Medical Centre is affiliated to St Joseph, University, Beirut

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: